Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroblastoma breakpoint family pseudogenes, such as those in the ENSG00000274019 locus, are non-protein-coding sequences duplicated from the NBPF gene family, which is most expanded in humans and primates. While the protein-coding NBPF genes have been implicated in nervous system development, brain size evolution, and various diseases including neuroblastoma and neurodevelopmental disorders, NBPF pseudogenes themselves do not encode proteins and are not validated as drug targets. The locus exhibits high copy number variation, which may alter expression levels of associated protein-coding genes and be involved in disease pathways such as microcephaly, autism, and schizophrenia, but no specific functional or therapeutic role is known for the pseudogenes themselves[2][6][1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroblastoma breakpoint family, pseudogene (NBPF pseudogene).